Literature DB >> 2918158

Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography.

C M Otto1, A S Pearlman, C L Gardner.   

Abstract

Doppler echocardiography was used to follow the hemodynamic severity of aortic stenosis. First, the reproducibility of repeat recordings (mean interval 28 +/- 36 days) of aortic jet velocity, made by two independent observers, was tested in 38 adults with aortic stenosis and unchanged clinical status. The two recordings of maximal velocity correlated well (r = 0.96, y = 0.88x + 0.46m/s, SEE = 0.21 m/s) with a mean coefficient of variation of 3.2%. Repeat recording of left ventricular outflow tract velocity by two independent observers in 10 other patients with aortic stenosis also correlated well (r = 0.94, y = 1.06x + 0.0 m/s, SEE = 0.06 m/s) with a mean coefficient of variation of 4.6%. Next, Doppler echocardiography was used to study 42 patients with aortic stenosis (mean age 66 years) over a follow-up interval of 6 to 43 months (mean 20). Maximal aortic jet velocity increased by 0.36 m/s per year (range -0.3 to +1.0 m/s per year). Mean transaortic pressure gradient changed by -7 to +23 (mean 8) mm Hg/year. Aortic valve area by the continuity equation (n = 25) decreased by 0 to 0.5 cm2/year (mean decrease 0.1 cm2/year). Some patients had a worsening of stenosis (decrease in valve area) even though they had no change or a decrease in pressure gradient, because of concurrent decreases in transaortic volume flow. Twenty-one patients (50%) developed new or progressive symptoms of aortic stenosis necessitating valve replacement.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2918158     DOI: 10.1016/0735-1097(89)90590-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  34 in total

Review 1.  Calcific aortic stenosis: from bench to the bedside--emerging clinical and cellular concepts.

Authors:  Nalini M Rajamannan; Bernard Gersh; Robert O Bonow
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

Review 2.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

3.  Is it time for medical therapy for aortic valve disease?

Authors:  Nalini M Rajamannan
Journal:  Expert Rev Cardiovasc Ther       Date:  2004-11

Review 4.  [Aortic stenosis].

Authors:  W G Daniel; H Baumgartner; C Gohlke-Bärwolf; P Hanrath; D Horstkotte; K C Koch; A Mügge; H J Schäfers; F A Flachskampf
Journal:  Clin Res Cardiol       Date:  2006-11       Impact factor: 5.460

5.  Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.

Authors:  Luis M Moura; Sandra F Ramos; José L Zamorano; Isabel M Barros; Luis F Azevedo; Francisco Rocha-Gonçalves; Nalini M Rajamannan
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

6.  Natural progression of low-gradient severe aortic stenosis with preserved ejection fraction.

Authors:  Antony Leslie Innasimuthu; Sanjay Kumar; Jason Lazar; William E Katz
Journal:  Tex Heart Inst J       Date:  2014-06-01

7.  Experimental analysis of fluid mechanical energy losses in aortic valve stenosis: importance of pressure recovery.

Authors:  R S Heinrich; A A Fontaine; R Y Grimes; A Sidhaye; S Yang; K E Moore; R A Levine; A P Yoganathan
Journal:  Ann Biomed Eng       Date:  1996 Nov-Dec       Impact factor: 3.934

Review 8.  Considerations in antithrombotic therapy among patients undergoing transcatheter aortic valve implantation.

Authors:  Donald R Lynch; David Dantzler; Mark Robbins; David Zhao
Journal:  J Thromb Thrombolysis       Date:  2013-05       Impact factor: 2.300

9.  Prognostic value of T1-mapping in TAVR patients: extra-cellular volume as a possible predictor for peri- and post-TAVR adverse events.

Authors:  Jonathan Nadjiri; Hanna Nieberler; Eva Hendrich; Albrecht Will; Costanza Pellegrini; Oliver Husser; Christian Hengstenberg; Andreas Greiser; Stefan Martinoff; Martin Hadamitzky
Journal:  Int J Cardiovasc Imaging       Date:  2016-07-26       Impact factor: 2.357

10.  Rapid progression of mitral and aortic stenosis in a patient with secondary hyperparathyroidism.

Authors:  K Fujise; R Amerling; W Sherman
Journal:  Br Heart J       Date:  1993-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.